241 related articles for article (PubMed ID: 19542051)
1. Robust docosahexaenoic acid-mediated neuroprotection in a rat model of transient, focal cerebral ischemia.
Belayev L; Khoutorova L; Atkins KD; Bazan NG
Stroke; 2009 Sep; 40(9):3121-6. PubMed ID: 19542051
[TBL] [Abstract][Full Text] [Related]
2. Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window.
Belayev L; Liu Y; Zhao W; Busto R; Ginsberg MD
Stroke; 2001 Feb; 32(2):553-60. PubMed ID: 11157196
[TBL] [Abstract][Full Text] [Related]
3. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats.
Eady TN; Belayev L; Khoutorova L; Atkins KD; Zhang C; Bazan NG
PLoS One; 2012; 7(10):e46151. PubMed ID: 23118851
[TBL] [Abstract][Full Text] [Related]
4. Docosahexaenoic acid complexed to albumin provides neuroprotection after experimental stroke in aged rats.
Eady TN; Khoutorova L; Obenaus A; Mohd-Yusof A; Bazan NG; Belayev L
Neurobiol Dis; 2014 Feb; 62():1-7. PubMed ID: 24063996
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats.
Eady TN; Khoutorova L; Anzola DV; Hong SH; Obenaus A; Mohd-Yusof A; Bazan NG; Belayev L
PLoS One; 2013; 8(10):e77237. PubMed ID: 24194876
[TBL] [Abstract][Full Text] [Related]
6. Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.
Bazan NG; Eady TN; Khoutorova L; Atkins KD; Hong S; Lu Y; Zhang C; Jun B; Obenaus A; Fredman G; Zhu M; Winkler JW; Petasis NA; Serhan CN; Belayev L
Exp Neurol; 2012 Jul; 236(1):122-30. PubMed ID: 22542947
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of treatment with human albumin in permanent focal cerebral ischemia: histopathology and cortical perfusion studies.
Liu Y; Belayev L; Zhao W; Busto R; Belayev A; Ginsberg MD
Eur J Pharmacol; 2001 Oct; 428(2):193-201. PubMed ID: 11675036
[TBL] [Abstract][Full Text] [Related]
9. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia.
Belayev L; Khoutorova L; Atkins K; Gordon WC; Alvarez-Builla J; Bazan NG
Exp Neurol; 2008 Dec; 214(2):253-8. PubMed ID: 18793637
[TBL] [Abstract][Full Text] [Related]
10. Docosahexaenoic acid complexed to human albumin in experimental stroke: neuroprotective efficacy with a wide therapeutic window.
Eady TN; Khoutorova L; Atkins KD; Bazan NG; Belayev L
Exp Transl Stroke Med; 2012 Sep; 4(1):19. PubMed ID: 22980673
[TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.
Belayev L; Marcheselli VL; Khoutorova L; Rodriguez de Turco EB; Busto R; Ginsberg MD; Bazan NG
Stroke; 2005 Jan; 36(1):118-23. PubMed ID: 15569878
[TBL] [Abstract][Full Text] [Related]
12. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD
Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675
[TBL] [Abstract][Full Text] [Related]
13. Emulsified Isoflurane Protects Against Transient Focal Cerebral Ischemia Injury in Rats via the PI3K/Akt Signaling Pathway.
Zhang H; Xiong X; Liu J; Gu L; Li F; Wan Y; Xu S
Anesth Analg; 2016 May; 122(5):1377-84. PubMed ID: 26859875
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
Huh PW; Belayev L; Zhao W; Clemens JA; Panetta JA; Busto R; Ginsberg MD
Eur J Pharmacol; 2000 Feb; 389(1):79-88. PubMed ID: 10686299
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia.
Sun M; Xu C
Cell Mol Neurobiol; 2008 Jun; 28(4):593-611. PubMed ID: 17712625
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia.
Briyal S; Shah S; Gulati A
Neuroscience; 2014 Dec; 281():269-81. PubMed ID: 25301749
[TBL] [Abstract][Full Text] [Related]
17. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
Pengyue Z; Tao G; Hongyun H; Liqiang Y; Yihao D
Biomed Pharmacother; 2017 Jun; 90():69-76. PubMed ID: 28343073
[TBL] [Abstract][Full Text] [Related]
18. Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact.
Chauveau F; Cho TH; Perez M; Guichardant M; Riou A; Aguettaz P; Picq M; Lagarde M; Berthezène Y; Nighoghossian N; Wiart M
Curr Neurovasc Res; 2011 May; 8(2):95-102. PubMed ID: 21443458
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid attenuates hyperglycemia-enhanced hemorrhagic transformation after transient focal cerebral ischemia in rats.
Lin Y; Xu M; Wan J; Wen S; Sun J; Zhao H; Lou M
Neuroscience; 2015 Aug; 301():471-9. PubMed ID: 26102005
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid confers enduring neuroprotection in experimental stroke.
Hong SH; Belayev L; Khoutorova L; Obenaus A; Bazan NG
J Neurol Sci; 2014 Mar; 338(1-2):135-41. PubMed ID: 24433927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
